Pulmonary Tuberculosis Incidence among Interferon-Gamma Release Assay-Positive Individuals with Latent Tuberculosis Infection and Fibrotic Lesions in a Vulnerable Urban Population in Osaka City, Japan, 2015

Pulmonary Tuberculosis Incidence among Interferon-Gamma Release Assay-Positive Individuals with Latent Tuberculosis Infection and Fibrotic Lesions in a Vulnerable Urban Population in Osaka City, Japan, 2015–2021

Published:2024-01-31 Issue:1 Volume:77 Page:21-24
ISSN:1344-6304
Container-title:Japanese Journal of Infectious Diseases
language:en
Short-container-title:Jpn J Infect Dis

Author:

Komukai Jun¹,Matsumoto Kenji²,Fukushima Wakaba³,Kudoh Shinzoh⁴

Affiliation:

1. Department of Infectious Disease Control, Osaka City Public Health Office, Japan

2. Faculty of Health and Nutrition, Otemae University, Japan

3. Department of Public Health, Research Center for Infectious Disease Sciences, Osaka Metropolitan University Graduate School of Medicine, Japan

4. Department of Internal Medicine, Osaka Social Medical Center, Japan

Publisher

Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://www.jstage.jst.go.jp/article/yoken/77/1/77_JJID.2023.277/_pdf

Reference14 articles.

1. 1. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60:555-564.

2. 2. Styblo K, van Geuns HA, Meijer J. The yield of active case-finding in persons with inactive pulmonary tuberculosis or fibrotic lesions. a 5-year study in tuberculosis clinics in Amsterdam, Rotterdam and Utrecht. Tubercle. 1984;65:237-251.

3. 3. Solsona Peiró J, de Souza Galvão ML, Altet Gómez MN, et al. Inactive fibrotic lesions versus pulmonary tuberculosis with negative bacteriology. Arch Bronconeumol. 2014;50:484-489.

4. 4. Diel R, Goletti D, Ferrara G, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011;37:88-99.

5. 5. Kahwati LC, Feltner C, Halpern M, et al. Primary care screening and treatment for latent tuberculosis infection in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;316:970-983.